Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
6.85
+0.10 (1.48%)
At close: Jun 6, 2025, 4:00 PM
6.75
-0.10 (-1.46%)
After-hours: Jun 6, 2025, 4:04 PM EDT
Lifecore Biomedical Employees
Lifecore Biomedical had 524 employees as of May 26, 2024. The number of employees increased by 65 or 14.16% compared to the previous year.
Employees
524
Change (1Y)
65
Growth (1Y)
14.16%
Revenue / Employee
$248,681
Profits / Employee
-$94,265
Market Cap
253.62M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
LFCR News
- 1 day ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Shareholders to Learn More About the Investigation - Accesswire
- 3 days ago - Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Accesswire
- 5 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Shareholders to Inquire about Securities Investigation - Accesswire
- 8 days ago - Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Accesswire
- 10 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Investors to Connect - Accesswire
- 11 days ago - Lifecore Biomedical Names Mark DaFonseca Chief Commercial Officer - GlobeNewsWire
- 12 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Stockholders to Inquire about Securities Investigation - Accesswire
- 15 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Investors to Learn More About the Investigation - Accesswire